Aloxi

Type: Product
Name: Aloxi
First reported Sep 24 2014 - Updated Sep 24 2014 - 1 reports

Patent Application Titled "Therapeutic Combinations of Netupitant and Palonosetron" Published Online

By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a patent application by the inventors Pietra, Claudio (Como, IT); Cantoreggi, Sergio (Cagiallo, CH), filed on ... [Published 4 Traders - Sep 24 2014]
First reported Sep 22 2014 - Updated Sep 23 2014 - 1 reports

Serotonin-blocking medicines used to treat nausea and vomiting

Safety advisory - risk of serotonin syndrome22 September 2014Consumers and health professionals are advised that serotonin syndrome is a newly identified issue associated with products containing the serotonin-blocking medicines classed as 5-HT3 receptor ... [Published Australian Dept. of Health - Sep 22 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

GreenWood Investors Q2 Investor Letter

“Mediocrity is not worth the effort.” -Sergio Marchionne at Fiat’s May, 2014 Investor DayDear GreenWood Investor:The entire purpose of this firm, and most of the financial industry staffed by human beings is to take advantage of opportunities created by ... [Published Seeking Alpha - Sep 18 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

PGR Report -- The Attack of 35 U.S.C. § 112

Last week, on September 2, 2014, Accord Healthcare, Inc. ("Accord") filed what appears to be the second-ever Post-Grant Review ("PGR") ( see   Petition ).  This PGR was for U.S. Patent No. 8,598,219 ("the '219 Patent"), which is jointly assigned to Helsinn ... [Published JD Supra - Sep 12 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

5E Nausea

ALOXI Eisai RxSelective 5-HT3 receptor antagonist. Palonosetron (as HCl) 0.075mg/1.5mL, 0.25mg/5mL; IV inj; contains mannitol.Indications: Prevention of acute nausea and vomiting due to initial and repeat courses of moderately and highly emetogenic chemotherapy ... [Published HighBeam Research - Sep 03 2014]
First reported Jun 22 2014 - Updated Jun 22 2014 - 1 reports

ALOXI (Palonosetron Hydrochloride) Injection [Eisai Inc.]

First reported May 30 2014 - Updated May 30 2014 - 2 reports

FDA approves Eisai's antiemetic agent ALOXI to treat children

The US Food and Drug Administration (FDA) has approved Japanese pharmaceutical firm Eisai's antiemetic agent ALOXI (palonosetron HCI) as an additional indication regarding the prevention of acute nausea and vomiting associated with initial and repeat ... [Published BioPortfolio - May 30 2014]
First reported May 28 2014 - Updated May 29 2014 - 3 reports

ALOXI injection receives FDA approval for prevention of nausea vomiting associated with cancer chemotherapy

Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemoth ... [Published BioPortfolio - May 29 2014]
First reported May 14 2014 - Updated May 15 2014 - 1 reports

Human medicines European public assessment report (EPAR): Aloxi, palonosetron, Revision: 18, Authorised

Entities: Aloxi, Humanism

Quotes

"The opposite effect is observed when the compounds are evaluated against various electrophysiological measures of pain control. In the course of these experiments, the inventors have discovered that netupitant has an independent effect, and that palonosetron exhibits zero or minimal effect. However, when the palonosetron is added to netupitant in therapeutically effective amounts, the palonosetron acts synergistically with the netupitant, and induces much greater control over electrophysiological measures of pain than when the netupitant is administered alone."

More Content

All (13) | News (9) | Reports (0) | Blogs (4) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Patent Application Titled "Therapeutic Combinat... [Published 4 Traders - Sep 24 2014]
Serotonin-blocking medicines used to treat naus... [Published Australian Dept. of Health - Sep 22 2014]
GreenWood Investors Q2 Investor Letter [Published Seeking Alpha - Sep 18 2014]
PGR Report -- The Attack of 35 U.S.C. § 112 [Published JD Supra - Sep 12 2014]
5E Nausea [Published HighBeam Research - Sep 03 2014]
ALOXI (Palonosetron Hydrochloride) Injection [E... [Published DailyMed Drug Label Updates for the last seven ... - Jun 22 2014]
FDA approves Eisai's antiemetic agent ALOXI to ... [Published BioPortfolio - May 30 2014]
FDA approves Eisai's antiemetic agent ALOXI to ... [Published PBR - News - May 30 2014]
ALOXI injection receives FDA approval for preve... [Published BioPortfolio - May 29 2014]
FDA Approves ALOXI to Prevent Chemotherapy Indu... [Published BioPortfolio - May 29 2014]
FDA Approves ALOXI® (palonosetron HCl) to Preve... [Published PR Newswire: Health - May 28 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - May 14 2014]
Helsinn, Mundipharma ink distribution and licen... [Published PharmaBiz - Dec 23 2013]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
ALOXI (Palonosetron Hydrochloride) Injection [E... [Published DailyMed Drug Label Updates for the last seven ... - Jun 22 2014]
Updated Date: Jun 19, 2014 EST ...
FDA approves Eisai's antiemetic agent ALOXI to ... [Published PBR - News - May 30 2014]
The US Food and Drug Administration (FDA) has approved Japanese pharmaceutical firm Eisai's antiemetic agent ALOXI (palonosetron HCI) as an additional indication regarding the prevention of acute nausea and vomiting associated with initial and repeat ...
FDA Approves ALOXI® (palonosetron HCl) to Preve... [Published PR Newswire: Health - May 28 2014]
WOODCLIFF LAKE, N.J. and LUGANO, Switzerland, May 28, 2014 /PRNewswire/ -- Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI® (palonosetron HCl) injection for the prevention of acute nausea and vomiting ...
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - May 14 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.